BAROSTIM THERAPY™ in Heart Failure With Reduced Ejection Fraction
NCT02880618 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500
Last updated 2023-04-20
Summary
The purpose of this registry (NCT02880618) is to evaluate the effect of BAROSTIM THERAPY with the BAROSTIM NEO System in the commercial setting in subjects recently implanted under the CE-Marked indication for heart failure with reduced ejection fraction (HFrEF).
Conditions
Interventions
- DEVICE
-
Barostim Neo™ System
Sponsors & Collaborators
-
CVRx, Inc.
lead INDUSTRY
Principal Investigators
-
Jochen Müller-Ehmsen, PhD · Asklepios Klinik Altona
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-12-13
- Primary Completion
- 2024-07-31
- Completion
- 2024-07-31
Countries
- Germany
- Italy
Study Locations
More Related Trials
-
Carillon Mitral Contour System® for Reducing Functional Mitral Regurgitation
NCT02325830 ·Status: COMPLETED ·Phase: NA
-
Early Feasibility EXperience of Posterior Leaflet RestOration to REduce Mitral Regurgitation
NCT04098328 ·Status: TERMINATED
-
Use of DurAVR™ THV System in Subjects With Severe Aortic Stenosis: Early Feasibility Study
NCT05712161 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
A Feasibility Study of the Millipede Transcatheter Annuloplasty Ring System in Patients With Functional Mitral Regurgitation
NCT04147884 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Evaluation of the HeartWare Left Ventricular Assist Device for the Treatment of Advanced Heart Failure
NCT00751972 ·Status: COMPLETED ·Phase: NA
-
Frailty: Prevalence and Response to Left Ventricular Assist Device Therapy in Older Heart Failure Patients
NCT02156583 ·Status: COMPLETED
-
FAST PV and mGFR™ Technology in Congestive Heart Failure
NCT03808948 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Outcomes of CRT and MitraClip for Treatment of Low Ejection Fraction and Functional Mitral Regurgitation in HF
NCT02985268 ·Status: WITHDRAWN ·Phase: NA
-
Early Feasibility Study of the Neovasc Tiara™ Mitral Valve System
NCT02276547 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Atrioventricular Node Ablation in Patients With Atrial Fibrillation and Moderate Chronic Heart Failure
NCT01512381 ·Status: TERMINATED ·Phase: PHASE4
-
Cardiovascular Improvements With MV ASV Therapy in Heart Failure
NCT01953874 ·Status: TERMINATED ·Phase: NA
-
Early Feasibility Study of the Cardiac Implants Percutaneous Ring Annuloplasty System
NCT04890821 ·Status: RECRUITING ·Phase: NA
-
Feasibility of the AccuCinch® System for Left Ventricular Reshaping of the Mitral Apparatus to Reduce Functional Mitral Regurgitation and Improve Left Ventricular Function
NCT02153892 ·Status: COMPLETED ·Phase: NA
-
LVAD in Non Cardiac Transplant Candidates and Non Responders to Resynchronization
NCT01126944 ·Status: WITHDRAWN ·Phase: NA
-
Baroreflex Activation Therapy in Left Ventricular Assist Device Patients Study
NCT06195046 ·Status: WITHDRAWN ·Phase: NA
-
Reprieve System Pilot Study
NCT06272734 ·Status: RECRUITING ·Phase: NA
-
Optimization of Heart Failure (HF) Medical Therapy After Transcatheter Valve Intervention (TVI) in Patients With Heart Failure With Reduced Ejection Fraction (HFrEF)
NCT06667128 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Strain Imaging in Patients With Functional Mitral Regurgitation, Treated With MitraClip
NCT04218578 ·Status: COMPLETED
-
An Early Feasibility Study of the HighLife 28mm Trans-Septal Transcatheter Mitral Valve Replacement System
NCT04029337 ·Status: RECRUITING ·Phase: NA
-
ANTHEM-HFrEF Pivotal Study
NCT03425422 ·Status: TERMINATED ·Phase: NA
-
A Randomized Study of the MitraClip Device in Heart Failure Patients With Clinically Significant Functional Mitral Regurgitation
NCT01772108 ·Status: TERMINATED ·Phase: NA
-
Optimizing Clinical Outcomes in Patients Undergoing Mitral Transcatheter Edge-to-edge Repair (M-TEER) for Severe Functional Mitral Regurgitation Towards Improved Guideline-directed Medical Therapy
NCT06702527 ·Status: NOT_YET_RECRUITING
-
Paracor Ventricular Support System (PVSS) for Patients With Heart Failure
NCT00291551 ·Status: TERMINATED ·Phase: PHASE1
-
The HeartWare™ Ventricular Assist System as Destination Therapy of Advanced Heart Failure: the ENDURANCE Trial
NCT01166347 ·Status: COMPLETED ·Phase: NA
-
Percutaneously Delivered Automated Continual Fluid Removal System in Patients With Advanced Diuretic-Resistant Heart Failure
NCT06689553 ·Status: TERMINATED ·Phase: NA